{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:08:34Z","timestamp":1790381314571,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-016-1663-1","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T22:55:30Z","timestamp":1484002530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Absence of in vivo selection for K13 mutations after artemether\u2013lumefantrine treatment in Uganda"],"prefix":"10.1186","volume":"16","author":[{"given":"Betty","family":"Balikagala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouki","family":"Yatsushiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichiro","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Auma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Ntege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirianne Marie Q.","family":"Palacpac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Egwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Okello","family":"Onen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"1663_CR1","unstructured":"WHO. World Malaria Report 2014. Geneva: World Health Organization; 2014. www.who.int\/malaria\/\u2026\/world_malaria_report_2014\/wmr-2014-no-profiles.pdf . Accessed 4 Jan 2016."},{"key":"1663_CR2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","volume":"7","author":"RT Eastman","year":"2009","unstructured":"Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864\u201374.","journal-title":"Nat Rev Microbiol"},{"key":"1663_CR3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMc0900231","volume":"361","author":"H Noedl","year":"2009","unstructured":"Noedl H, Socheat D, Satimai W. Artemisinin-resistant malaria in Asia. N Engl J Med. 2009;361:540\u20131.","journal-title":"N Engl J Med"},{"key":"1663_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"1663_CR5","unstructured":"Word Health Organization Global Malaria Programme. Status report on artemisinin resistance, September 2014. http:\/\/www.who.int\/malaria\/publications\/atoz\/status_rep_artemisinin_resistance_sep2014.pdf . Accessed 16 Nov 2015."},{"key":"1663_CR6","doi-asserted-by":"crossref","first-page":"e1001119","DOI":"10.1371\/journal.pmed.1001119","volume":"8","author":"Four Artemisinin-Based Combinations (4ABC) Study Group","year":"2011","unstructured":"Four Artemisinin-Based Combinations (4ABC) Study Group. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011;8:e1001119.","journal-title":"PLoS Med"},{"key":"1663_CR7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124.","journal-title":"Science"},{"key":"1663_CR8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/infdis\/jir664","volume":"204","author":"T Mita","year":"2011","unstructured":"Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, et al. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis. 2011;204:1980\u20138.","journal-title":"J Infect Dis"},{"key":"1663_CR9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dkn482","volume":"63","author":"T Mita","year":"2009","unstructured":"Mita T, Tanabe K, Takahashi N, Culleton R, Ndounga M, Dzodzomenyo M, et al. Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J Antimicrob Chemother. 2009;63:252\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"1663_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","volume":"58","author":"T Mita","year":"2009","unstructured":"Mita T, Tanabe K, Kita K. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int. 2009;58:201\u20139.","journal-title":"Parasitol Int"},{"key":"1663_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"1663_CR12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"},{"key":"1663_CR13","unstructured":"MalariaGen. P. falciparum Community Project data (beta release). Oxford: MalariaGen, 2015. https:\/\/elifesciences.org\/content\/5\/e08714 . Accessed 18 Aug 2016."},{"key":"1663_CR14","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"1663_CR15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/infdis\/jiu141","volume":"210","author":"MD Conrad","year":"2014","unstructured":"Conrad MD, LeClair N, Arinaitwe E, Wanzira H, Kakuru A, Bigira V, et al. Comparative impacts over 5\u00a0years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. J Infect Dis. 2014;210:344\u201353.","journal-title":"J Infect Dis"},{"key":"1663_CR16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/596738","volume":"199","author":"C Sisowath","year":"2009","unstructured":"Sisowath C, Petersen I, Veiga MI, M\u00e5rtensson A, Premji Z, Bj\u00f6rkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether\u2013lumefantrine in Africa. J Infect Dis. 2009;199:750\u20137.","journal-title":"J Infect Dis"},{"key":"1663_CR17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1128\/AAC.00968-08","volume":"53","author":"CT Happi","year":"2009","unstructured":"Happi CT, Gbotosho GO, Folarin OA, Sowunmi A, Hudson T, O\u2019Neil M, et al. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether\u2013lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2009;53:888\u201395.","journal-title":"Antimicrob Agents Chemother"},{"key":"1663_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12936-016-1095-y","volume":"15","author":"J Muwanguzi","year":"2016","unstructured":"Muwanguzi J, Henriques G, Sawa P, Bousema T, Sutherland CJ, Beshir KB. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children. Malar J. 2016;15:36.","journal-title":"Malar J."},{"key":"1663_CR19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","volume":"213","author":"A Yeka","year":"2016","unstructured":"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, et al. Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial. J Infect Dis. 2016;213:1134\u201342.","journal-title":"J Infect Dis"},{"key":"1663_CR20","doi-asserted-by":"crossref","first-page":"e113311","DOI":"10.1371\/journal.pone.0113311","volume":"9","author":"A Yeka","year":"2014","unstructured":"Yeka A, Lameyre V, Afizi K, Fredrick M, Lukwago R, Kamya MR, et al. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether\u2013lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. PLoS ONE. 2014;9:e113311.","journal-title":"PLoS ONE"},{"key":"1663_CR21","doi-asserted-by":"crossref","first-page":"e53772","DOI":"10.1371\/journal.pone.0053772","volume":"8","author":"A Yeka","year":"2013","unstructured":"Yeka A, Tibenderana J, Achan J, D\u2019Alessandro U, Talisuna AO. Efficacy of quinine, artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine as rescue treatment for uncomplicated malaria in Ugandan children. PLoS ONE. 2013;8:e53772.","journal-title":"PLoS ONE"},{"key":"1663_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2875-13-32","volume":"13","author":"MK Muhindo","year":"2014","unstructured":"Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:32.","journal-title":"Malar J."},{"key":"1663_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0583-9","volume":"14","author":"J Kapisi","year":"2015","unstructured":"Kapisi J, Bigira V, Clark T, Kinara S, Mwangwa F, Achan J, et al. Efficacy and safety of artemether\u2013lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens. Malar J. 2015;14:1.","journal-title":"Malar J."},{"key":"1663_CR24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1086\/647946","volume":"49","author":"E Arinaitwe","year":"2009","unstructured":"Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, et al. Artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis. 2009;49:1629\u201337.","journal-title":"Clin Infect Dis"},{"key":"1663_CR25","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.pctr.0020020","volume":"2","author":"MR Kamya","year":"2007","unstructured":"Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, et al. Artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials. 2007;2:e20.","journal-title":"PLoS Clin Trials."},{"key":"1663_CR26","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.pctr.0010007","volume":"1","author":"H Bukirwa","year":"2006","unstructured":"Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, et al. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials. 2006;1:e7.","journal-title":"PLoS Clin Trials."},{"key":"1663_CR27","doi-asserted-by":"crossref","first-page":"e2390","DOI":"10.1371\/journal.pone.0002390","volume":"3","author":"A Yeka","year":"2008","unstructured":"Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, et al. Artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS ONE. 2008;3:e2390.","journal-title":"PLoS ONE"},{"key":"1663_CR28","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1001\/jama.297.20.2210","volume":"297","author":"G Dorsey","year":"2007","unstructured":"Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007;297:2210\u20139.","journal-title":"JAMA"},{"key":"1663_CR29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4269\/ajtmh.2006.74.413","volume":"74","author":"DT McNamara","year":"2006","unstructured":"McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, Zimmerman PA. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction\/ligase detection reaction fluorescent microsphere-based assay. Am J Trop Med Hyg. 2006;74:413\u201321.","journal-title":"Am J Trop Med Hyg"},{"key":"1663_CR30","unstructured":"Uganda Bureau of Statistics. Uganda Malaria Indicator Survey 2009. https:\/\/dhsprogram.com\/pubs\/pdf\/MIS6\/MIS6.pdf . Accessed 8 Jan 2016."},{"key":"1663_CR31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4269\/ajtmh.2006.75.219","volume":"75","author":"PE Okello","year":"2006","unstructured":"Okello PE, Van Bortel W, Byaruhanga AM, Correwyn A, Roelants P, Talisuna A, et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg. 2006;75:219\u201325.","journal-title":"Am J Trop Med Hyg"},{"key":"1663_CR32","unstructured":"Uganda Bureau of Statistics (UBOS) and ICF International 2015. Uganda Malaria Indicator Survey 2014\u20132015. https:\/\/dhsprogram.com\/pubs\/pdf\/MIS21\/MIS21.pdf . Accessed 8 Jan 2016."},{"key":"1663_CR33","unstructured":"World Health Organization. Methods for surveillance of antimalarial drug efficacy. http:\/\/apps.who.int\/iris\/bitstream\/10665\/44048\/1\/9789241597531_eng.pdf . Accessed 10 Jan 2016."},{"key":"1663_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/expr.2000.4591","volume":"97","author":"N Sakihama","year":"2001","unstructured":"Sakihama N, Mitamura T, Kaneko A, Horii T, Tanabe K. Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots. Exp Parasitol. 2001;97:50\u20134.","journal-title":"Exp Parasitol"},{"key":"1663_CR35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4269\/ajtmh.1999.60.183","volume":"60","author":"JM Rubio","year":"1999","unstructured":"Rubio JM, Benito A, Roche J, Berzosa PJ, Garcia ML, Mico M, et al. Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. Am J Trop Med Hyg. 1999;60:183\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"1663_CR36","first-page":"375","volume":"23","author":"K Tanabe","year":"1999","unstructured":"Tanabe K, Sakihama N, Kaneko O, Saito A, Kimura M. A PCR Method for molecular epidemiology of Plasmodium falciparum Msp-1. Tokai J Exp Clin Med. 1999;23:375\u201381.","journal-title":"Tokai J Exp Clin Med"},{"key":"1663_CR37","unstructured":"Worldwide Antimalarial Resistance Network-Tools and resources\/procedures. http:\/\/www.wwarn.org\/tools-resources\/procedures . Accessed 8 Dec 2016."},{"key":"1663_CR38","unstructured":"Imagej.nih.gov. https:\/\/imagej.nih.gov\/ij . Accessed 9 Dec 2016."},{"key":"1663_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-6851(00)00201-2","volume":"108","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000;108:13\u201323.","journal-title":"Mol Biochem Parasitol"},{"key":"1663_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1475-2875-11-92","volume":"11","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Tanabe K, Tsukahara T, Dzodzomenyo M, Dysoley L, Khamlome B, et al. Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt. Malar J. 2012;11:92.","journal-title":"Malar J."},{"key":"1663_CR41","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","volume":"30","author":"K Tamura","year":"2013","unstructured":"Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725\u20139.","journal-title":"Mol Biol Evol"},{"key":"1663_CR42","unstructured":"PlasmoDB database. http:\/\/plasmodb.org\/plasmo\/app\/record\/gene\/PF3D7_1343700 . Accessed 7 Jan 2015."},{"key":"1663_CR43","unstructured":"WHO. Global plan for artemisinin resistance containment (GPARC). Geneva: World Health Organization. http:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin_resistance_containment_2011.pdf . Accessed 7 Jan 2016."},{"key":"1663_CR44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-015-0445-x","volume":"13","author":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group","year":"2015","unstructured":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Med. 2015;13:212.","journal-title":"BMC Med"},{"key":"1663_CR45","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/infdis\/jit431","volume":"208","author":"KB Beshir","year":"2013","unstructured":"Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013;208:2017\u201324.","journal-title":"J Infect Dis"},{"key":"1663_CR46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1475-2875-10-380","volume":"10","author":"AM Carlsson","year":"2011","unstructured":"Carlsson AM, Ngasala BE, Dahlstr\u00f6m S, Membi C, Veiga IM, Rombo L, et al. Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Malar J. 2011;10:380.","journal-title":"Malar J."},{"key":"1663_CR47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1586\/14787210.2016.1106938","volume":"14","author":"T Mita","year":"2016","unstructured":"Mita T, Tachibana SI, Hashimoto M, Hirai M. Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites. Expert Rev Anti Infect Ther. 2016;14:125\u201335.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1663_CR48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12936-016-1206-9","volume":"15","author":"L Paloque","year":"2016","unstructured":"Paloque L, Ramadani AP, Mercereau-Puijalon O, Augereau JM, Benoit-Vical F. Plasmodium falciparum: multifaceted resistance to artemisinins. Malar J. 2016;15:149.","journal-title":"Malar J."},{"key":"1663_CR49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2164-12-391","volume":"12","author":"S Mok","year":"2011","unstructured":"Mok S, Imwong M, Mackinnon MJ, Sim J, Ramadoss R, Yi P, et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genom. 2011;12:391.","journal-title":"BMC Genom"},{"key":"1663_CR50","doi-asserted-by":"crossref","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","volume":"13","author":"C Dogovski","year":"2015","unstructured":"Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, et al. Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance. PLoS Biol. 2015;13:e1002132.","journal-title":"PLoS Biol"},{"key":"1663_CR51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1475-2875-13-431","volume":"13","author":"AN Mohon","year":"2014","unstructured":"Mohon AN, Alam MS, Bayih AG, Folefoc A, Shahinas D, Haque R, et al. Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009\u20132013). Malar J. 2014;13:431.","journal-title":"Malar J."},{"key":"1663_CR52","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3201\/eid2107.150213","volume":"21","author":"M Hawkes","year":"2015","unstructured":"Hawkes M, Conroy AL, Opoka RO, Namasopo S, Zhong K, Liles WC, et al. Slow clearance of Plasmodium falciparum in severe pediatric malaria, Uganda, 2011\u20132013. Emerg Infect Dis. 2015;21:1237\u20139.","journal-title":"Emerg Infect Dis"},{"key":"1663_CR53","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.4269\/ajtmh.14-0605","volume":"92","author":"A Ouattara","year":"2015","unstructured":"Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, et al. Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali. Am J Trop Med Hyg. 2015;92:1202\u20136.","journal-title":"Am J Trop Med Hyg."},{"key":"1663_CR54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","volume":"15","author":"Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group","year":"2015","unstructured":"Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. The effect of dose on the antimalarial efficacy of artemether\u2013lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infect Dis. 2015;15:692\u2013702.","journal-title":"Lancet Infect Dis."},{"key":"1663_CR55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.2.5759.445","volume":"2","author":"A Adeloye","year":"1971","unstructured":"Adeloye A, Luzzatto L, Edington GM. Severe malarial infection in a patient with sickle-cell anaemia. BMJ. 1971;2:445.","journal-title":"BMJ"},{"key":"1663_CR56","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4269\/ajtmh.2001.65.614","volume":"65","author":"RN Price","year":"2001","unstructured":"Price RN, Simpson JA, Nosten FR, Luxemburger CH, Hkirjaroen LI, ter Kuile FE, et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65:614\u201322.","journal-title":"Am J Trop Med Hyg"},{"key":"1663_CR57","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","volume":"210","author":"G Henriques","year":"2014","unstructured":"Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001\u20138.","journal-title":"J Infect Dis"},{"key":"1663_CR58","first-page":"17","volume":"40","author":"Y Birku","year":"2002","unstructured":"Birku Y, Mekonnen E, Bj\u00f6rkman A, Wolday D. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Ethiop Med J. 2002;40:17\u201326.","journal-title":"Ethiop Med J"},{"key":"1663_CR59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cid\/ciu286","volume":"59","author":"A Kakuru","year":"2014","unstructured":"Kakuru A, Achan J, Muhindo MK, Ikilezi G, Arinaitwe E, Mwangwa F, et al. Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. Clin Infect Dis. 2014;59:446\u201353.","journal-title":"Clin Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T09:47:04Z","timestamp":1568713624000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1663-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1663-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]},"article-number":"23"}}